Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din, Mona Mansour Salem, Dina Ossama Abdulazim

Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal function Saúl Pampa-Saico, Vicente Pintado, Alfonso Muriel, Fernando Caravaca-Fontan, Estefanía Yerovi-León, Aurora Rojo-Sanchis, José M. del Rey, M. Teresa Tenorio, Fernando Liaño

ACSL1: A preliminary study that provides a new target for the treatment of renal fibrosis could bring new insights in diabetic kidney disease Zhonghui Cao, Xiao Gao, Jing Meng, Xiaoli Guo, Jiahao Xu, Junchao Cui, Xueyan Zhou